Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Currenc Group Inc
(OP:
CURR
)
N/A
UNCHANGED
Last Price
Updated: 3:04 PM EDT, Aug 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Currenc Group Inc
< Previous
1
2
Next >
Avenir Wellness Solutions Reports Third Quarter 2023 Results
November 14, 2023
Via
ACCESSWIRE
Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
August 08, 2023
Via
ACCESSWIRE
Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins
July 31, 2023
Via
ACCESSWIRE
Avenir Wellness Solutions Update to Stockholders
May 17, 2023
Via
ACCESSWIRE
Wide Marketing and Shipments Commenced for New Patent Pending DNA Complex Skin Care Used by Top Movie and TV Star Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
May 02, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
April 26, 2023
Via
ACCESSWIRE
Avenir Wellness Letter to Stockholders
April 25, 2023
Via
ACCESSWIRE
Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
March 16, 2023
Via
ACCESSWIRE
CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
January 17, 2023
Via
ACCESSWIRE
CURE Pharmaceutical Letter to Shareholders
December 15, 2022
Via
ACCESSWIRE
Most Powerful Anti-Aging Product Lines with Patent Pending DNA Complex; Endorsed by Oscars Night 2023 Presenter Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
March 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
February 13, 2023
Via
ACCESSWIRE
Nicole Kidman Endorsed Wellness and Beauty Products; On-Track for Accelerated Sales Growth with Company Rebranded as Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
January 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
January 19, 2023
Via
ACCESSWIRE
CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
November 22, 2022
Via
ACCESSWIRE
Anti-Aging Wellness Products; Q3 Revenues Surge; $20 Million non-dilutive IP Asset Sale: Cure Pharmaceutical Inc. (Stock Symbol: CURR)
November 28, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
$20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)
September 21, 2022
Via
Get News
CURE Pharmaceuticals Holding Corp. (CURR) Featured in Virtual Coverage of NIBA’s 148th Investment Conference
August 30, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
$20 Million sale of IP Platform Technology; Health and Beauty Lines Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
July 29, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Marketing Partnerships for Advanced Health and Beauty Lines; Products Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
May 10, 2022
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
April 27, 2022
LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at...
From
Stock News Now
Via
AccessWire
Patented Oral Thin Film Drug Delivery Advancements with Applications on Key Health & Beauty Products; Partnered with Super Star Nicole Kidman: CURE Pharmaceutical (OTCQB: CURR)
January 25, 2022
Via
Get News
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
August 17, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
June 15, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
June 10, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be...
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign
June 09, 2021
From
Sera Labs
Via
Business Wire
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
May 25, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
CURE Pharma (Stock Symbol: CURR) Q1 Revenue Quadruples to $1.5 million; Marketing Strength Grows with ISO Certification
May 18, 2021
(Stock Symbol: CURR), Sees Q1 Revenues Jump Fourfold; Marketing Strength Grows with Recent ISO Certification and Expansion of New Biopharma Product Lines
Via
EIN Presswire
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
May 17, 2021
From
CURE Pharmaceutical Holding Corp.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.